Altamira Therapeutics Ltd. buy nefets
Start price
18.07.16
/
50%
€68.01
Target price
18.01.17
€135.30
Performance (%)
-70.85%
End price
18.01.17
€19.82
Summary
This prediction ended on 18.01.17 with a price of €19.82. The BUY prediction by nefets for Altamira Therapeutics Ltd. performed very badly with a performance of -70.85%. nefets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Altamira Therapeutics Ltd. | - | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
Comments by nefets for this prediction
In the thread Altamira Therapeutics Ltd. diskutieren
nefets stimmt der fundamentalen Bewertung mit dem Ergebnis 'unterbewertet' zu
nefets stimmt am 18.07.2016 der fundamentalen Bewertung mit dem Ergebnis unterbewertet zu. Fundamental auf gutem Zulassungsweg.
(Laufzeit überschritten)
Stopped prediction by nefets for Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd.
Start price
Target price
Perf. (%)
€0.82
13.05.20
13.05.20
€0.000
04.11.21
04.11.21
70.73%
05.11.21
05.11.21